Search

everythinglearnresearchcommunity

for

Search:↓

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

The document's conclusion cannot be provided because the document is not available or cannot be read.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Consider rare forms of CAH for accurate diagnosis and treatment.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

CYP11A1 is crucial for skin health and disease by producing important steroids.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

A genetic mutation in a specific gene causes a salt-wasting condition in a Pakistani girl and her family.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

21-hydroxylase deficiency causes hormone imbalances leading to various symptoms, and diagnosis involves clinical and genetic tests.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Non-classical 21-hydroxylase deficiency can be missed in newborn screenings and should be considered in cases of early puberty or virilization.